Save 20% on Press Releases and More with NNW Prime! Click to View Details
MondayMar 24, 2025 11:00 am

NetworkNewsBreaks – Thumzup Media Corp. (NASDAQ: TZUP) Reports Insider Stock Purchases and Accelerated Buybacks

Thumzup (NASDAQ: TZUP), an emerging player in social media branding and programmatic marketing, reported that company insiders acquired approximately $60,381 in common stock during the March 2025 trading window, following $62,000 in purchases in Dec. 2024. Cumulatively, insiders have invested over $740,000 in the company since inception. Thumzup also repurchased about $216,000 worth of stock in the past three trading days under its $1 million buyback program, signaling continued confidence in its growth trajectory. The company recently surpassed 700 advertisers and maintains a CAGR above 200 percent.  To view the full press release, visit https://nnw.fm/Ec6A7  About Thumzup®  Thumzup Media Corporation…

Continue Reading

MondayMar 24, 2025 10:43 am

NetworkNewsBreaks – Clene Inc. (NASDAQ: CLNN) Plans 2025 NDA Submission Following Positive ALS Trial Data 

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company, reported a full-year 2024 net loss of $39.4 million, or $5.67 per share, compared to a loss of $49.5 million in 2023. Revenue remained limited, but Clene highlighted regulatory progress and survival data supporting CNM-Au8, its gold nanocrystal suspension for ALS. The company expects to meet with the FDA in Q2 2025 to finalize analysis plans for biomarker data, with a potential accelerated NDA submission in the second half of 2025. Clene ended the year with $12.2 million in cash and expects to begin enrollment for its confirmatory Phase 3 RESTORE-ALS trial in…

Continue Reading

MondayMar 24, 2025 9:20 am

NetworkNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Highlights Juve Stabia Academy as Key Youth Football Investment

Brera Holdings (NASDAQ: BREA), an Ireland-based international holding company focused on multi-club ownership, spotlighted the Juve Stabia Academy for its role in developing elite football talent in the Naples Metropolitan Area. The investment reflects Brera’s strategy to support grassroots football and create a global network of academies. Juve Stabia has a history of producing top-tier talent, including Luigi Vitale and Antonio Donnarumma, and aligns with Brera’s mission to strengthen football ecosystems and expand pathways for emerging players worldwide. To view the full press release, visit https://nnw.fm/pv5ES About Brera Holdings PLC Brera Holdings PLC is focused on expanding its social impact…

Continue Reading

FridayMar 21, 2025 3:16 pm

NetworkNewsBreaks – Upstream at the Forefront of the Shift Toward Expanded Trading 

Upstream published a blog today that discussed challenges faced by legacy stock exchanges transitioning to 24/5 trading, outlining obstacles such as outdated infrastructure, regulatory hurdles, operational constraints for brokers and clearing firms, liquidity fragmentation, and cybersecurity risks. Significant upgrades are needed for traditional exchanges to support real-time settlement and extended trading hours. On the other hand, blockchain-powered platforms like Upstream are designed to overcome these hurdles. Upstream enables 20/7, peer-to-peer trading, liquidity, a fair trading ecosystem, and biometric authentication and smart contracts to ensure transparency and security. Upstream believes continuous market access is the future and is committed to driving…

Continue Reading

FridayMar 21, 2025 1:52 pm

NetworkNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI): Poised in the Future of Oncology with Cutting-Edge Treatments

Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage biotechnology company at the forefront of research and development of innovative treatments in the field of immuno-oncology. With cancer being the second leading cause of death globally, the company focuses on harnessing antitumor virotherapies and patented technologies designed to protect and potentiate the virotherapy during administration to combat cancer more effectively and with fewer side effects. The company’s approach includes a systemic platform using extracellular enveloped viruses and an intratumoral platform utilizing stem cells to protect the therapy from the body’s immune system during administration. Calidi’s pipeline includes promising therapies such as RTNova,…

Continue Reading

FridayMar 21, 2025 12:24 pm

NetworkNewsBreaks – Clene Inc. (NASDAQ: CLNN) Unveils Progress on CNM-Au8(R), Eyes Potential Fast-Track FDA Approval

Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), is actively advancing its lead drug candidate, CNM-Au8®. The company presented its progress at two key investor events this month, including the Q1 Virtual Investor Summit and the 37th Annual Roth Conference. At both events, Clene’s management discussed the latest achievements with CNM-Au8, a gold nanocrystal-based oral suspension that targets mitochondrial dysfunction and promotes neuronal health. The drug has shown promising results in…

Continue Reading

FridayMar 21, 2025 11:50 am

NetworkNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Announces Key Milestones and 2024 Financial Results

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, today announced its recent accomplishments and financial results for the year ended Dec. 31, 2024. “We remain highly focused on advancing our multiple clinical programs as we work towards achieving a number of important and potentially transformational development milestones, including top-line results in 2026 for our actively enrolling confirmatory Phase 3 placebo-controlled study evaluating HyBryte(TM) (synthetic hypericin) in the treatment of early-stage cutaneous T-cell lymphoma (‘CTCL’),” stated Christopher J. Schaber, PhD, president and chief executive officer…

Continue Reading

FridayMar 21, 2025 10:16 am

NetworkNewsBreaks – General Mills, Inc. (NYSE: GIS) Reports Mixed Q3 2025 Results, Updates Outlook 

General Mills (NYSE: GIS) announced its third-quarter fiscal 2025 results, reporting earnings per share (“EPS”) of $1.00, surpassing analyst expectations of $0.98. However, revenue fell short, totaling $4.8 billion against a projected $4.99 billion. The company attributed the revenue miss to greater-than-expected retailer inventory headwinds and a slowdown in U.S. snacking categories. In response, General Mills plans to invest in consumer value, media support, and in-store visibility in the fourth quarter to drive growth.  To view the full article, visit https://nnw.fm/9OrCk  About General Mills  General Mills makes food the world loves. The company is guided by its Accelerate strategy to…

Continue Reading

FridayMar 21, 2025 9:49 am

NetworkNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Unveils Quantum-Powered Blockchain Architecture 

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, has introduced a novel blockchain architecture that incorporates quantum computing techniques to enhance security and efficiency. The company’s new research paper, Blockchain with Proof of Quantum Work, details how a “proof of quantum” algorithm utilizes quantum computation to generate and validate blockchain hashes. D-Wave deployed this architecture across four of its cloud-based annealing quantum computers located in Canada and the U.S., marking the first instance of distributed quantum computing for blockchain. The research indicates that using quantum computation for hashing and proof of work could…

Continue Reading

ThursdayMar 20, 2025 1:45 pm

NetworkNewsBreaks – Thumzup Media Corp. (NASDAQ: TZUP) Repurchases $126,507 in Common Stock 

Thumzup (NASDAQ: TZUP), a growing force in social media branding and programmatic marketing, announced the repurchase of $126,507 of its common stock as part of its previously approved $1 million buyback program. The company views the repurchase as a strategic move to enhance shareholder value and reinforce confidence in its growth trajectory. CEO Robert Steele highlighted the buyback as a demonstration of Thumzup's commitment to capital efficiency and long-term value creation. The company has also reported surpassing 700 advertisers on its platform, with a compound annual growth rate exceeding 200%.  To view the full press release, visit https://nnw.fm/ggcaF  About Thumzup® …

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000